453 related articles for article (PubMed ID: 26195725)
1. Identification of resolvin D2 receptor mediating resolution of infections and organ protection.
Chiang N; Dalli J; Colas RA; Serhan CN
J Exp Med; 2015 Jul; 212(8):1203-17. PubMed ID: 26195725
[TBL] [Abstract][Full Text] [Related]
2. Novel Resolvin D2 Receptor Axis in Infectious Inflammation.
Chiang N; de la Rosa X; Libreros S; Serhan CN
J Immunol; 2017 Jan; 198(2):842-851. PubMed ID: 27994074
[TBL] [Abstract][Full Text] [Related]
3. Resolvin D2 limits atherosclerosis progression via myeloid cell-GPR18.
Lipscomb M; Walis S; Marinello M; Mena HA; MacNamara KC; Spite M; Fredman G
FASEB J; 2024 Mar; 38(6):e23555. PubMed ID: 38498346
[TBL] [Abstract][Full Text] [Related]
4. Identification of Chemotype Agonists for Human Resolvin D1 Receptor DRV1 with Pro-Resolving Functions.
Chiang N; Barnaeva E; Hu X; Marugan J; Southall N; Ferrer M; Serhan CN
Cell Chem Biol; 2019 Feb; 26(2):244-254.e4. PubMed ID: 30554914
[TBL] [Abstract][Full Text] [Related]
5. The resolvin D2 - GPR18 axis is expressed in human coronary atherosclerosis and transduces atheroprotection in apolipoprotein E deficient mice.
Bardin M; Pawelzik SC; Lagrange J; Mahdi A; Arnardottir H; Regnault V; Fève B; Lacolley P; Michel JB; Mercier N; Bäck M
Biochem Pharmacol; 2022 Jul; 201():115075. PubMed ID: 35525326
[TBL] [Abstract][Full Text] [Related]
6. Resolvin D2 and its receptor GPR18 in cardiovascular and metabolic diseases: A promising biomarker and therapeutic target.
Zhao M; Zheng Z; Yin Z; Zhang J; Qin J; Wan J; Wang M
Pharmacol Res; 2023 Sep; 195():106832. PubMed ID: 37364787
[TBL] [Abstract][Full Text] [Related]
7. Resolvin D2 Enhances Postischemic Revascularization While Resolving Inflammation.
Zhang MJ; Sansbury BE; Hellmann J; Baker JF; Guo L; Parmer CM; Prenner JC; Conklin DJ; Bhatnagar A; Creager MA; Spite M
Circulation; 2016 Aug; 134(9):666-680. PubMed ID: 27507404
[TBL] [Abstract][Full Text] [Related]
8. Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis.
Spite M; Norling LV; Summers L; Yang R; Cooper D; Petasis NA; Flower RJ; Perretti M; Serhan CN
Nature; 2009 Oct; 461(7268):1287-91. PubMed ID: 19865173
[TBL] [Abstract][Full Text] [Related]
9. GPR101 mediates the pro-resolving actions of RvD5n-3 DPA in arthritis and infections.
Flak MB; Koenis DS; Sobrino A; Smith J; Pistorius K; Palmas F; Dalli J
J Clin Invest; 2020 Jan; 130(1):359-373. PubMed ID: 31793912
[TBL] [Abstract][Full Text] [Related]
10. GPR18 Agonist Resolvin D2 Reduces Early Brain Injury in a Rat Model of Subarachnoid Hemorrhage by Multiple Protective Mechanisms.
Zhang T; Zuo G; Zhang H
Cell Mol Neurobiol; 2022 Oct; 42(7):2379-2392. PubMed ID: 34089427
[TBL] [Abstract][Full Text] [Related]
11. Resolvin D2-GPR18 Signaling on Myeloid Cells Limits Plaque Necrosis.
Lipscomb M; Walis S; Marinello M; Mena HA; Spite M; Fredman G
bioRxiv; 2023 Apr; ():. PubMed ID: 37066358
[TBL] [Abstract][Full Text] [Related]
12. Resolvin D2/GPR18 signaling enhances monocytic myeloid-derived suppressor cell function to mitigate abdominal aortic aneurysm formation.
Bellotti P; Ladd Z; Leroy V; Su G; Sharma S; Hartman JB; Krebs J; Viscardi C; Maile R; Moldawer LL; Efron P; Sharma AK; Upchurch GR
bioRxiv; 2024 Feb; ():. PubMed ID: 38464077
[TBL] [Abstract][Full Text] [Related]
13. Maresin 1 activates LGR6 receptor promoting phagocyte immunoresolvent functions.
Chiang N; Libreros S; Norris PC; de la Rosa X; Serhan CN
J Clin Invest; 2019 Dec; 129(12):5294-5311. PubMed ID: 31657786
[TBL] [Abstract][Full Text] [Related]
14. Resolvin D2 decreases TLR4 expression to mediate resolution in human monocytes.
Croasdell A; Sime PJ; Phipps RP
FASEB J; 2016 Sep; 30(9):3181-93. PubMed ID: 27256622
[TBL] [Abstract][Full Text] [Related]
15. Resolvin D1 binds human phagocytes with evidence for proresolving receptors.
Krishnamoorthy S; Recchiuti A; Chiang N; Yacoubian S; Lee CH; Yang R; Petasis NA; Serhan CN
Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1660-5. PubMed ID: 20080636
[TBL] [Abstract][Full Text] [Related]
16. Resolvin D2 prevents vascular remodeling, hypercontractility and endothelial dysfunction in obese hypertensive mice through modulation of vascular and proinflammatory factors.
Rodrigues-Diez R; Ballesteros-Martinez C; Moreno-Carriles RM; Nistal F; Díaz Del Campo LS; Cachofeiro V; Dalli J; García-Redondo AB; Redondo JM; Salaices M; Briones AM
Biomed Pharmacother; 2024 May; 174():116564. PubMed ID: 38608525
[TBL] [Abstract][Full Text] [Related]
17. Resolvin D2 uses multiple Ca
Botten N; Hodges RR; Bair J; Utheim TP; Serhan CN; Yang M; Dartt DA
J Cell Physiol; 2022 Oct; 237(10):3816-3833. PubMed ID: 36066128
[TBL] [Abstract][Full Text] [Related]
18. Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent.
Orr SK; Colas RA; Dalli J; Chiang N; Serhan CN
Am J Physiol Lung Cell Mol Physiol; 2015 May; 308(9):L904-11. PubMed ID: 25770181
[TBL] [Abstract][Full Text] [Related]
19. The Resolvin D2-GPR18 Axis Enhances Bone Marrow Function and Limits Hepatic Fibrosis in Aging.
Fitzgerald H; Bonin JL; Sadhu S; Lipscomb M; Biswas N; Decker C; Nabage M; Bossardi R; Marinello M; Mena AH; Gilliard K; Spite M; Adam A; MacNamara KC; Fredman G
bioRxiv; 2023 Jan; ():. PubMed ID: 36711905
[TBL] [Abstract][Full Text] [Related]
20. Uncovering the Power of GPR18 Signalling: How RvD2 and Other Ligands Could Have the Potential to Modulate and Resolve Inflammation in Various Health Disorders.
Honkisz-Orzechowska E; Łażewska D; Baran G; Kieć-Kononowicz K
Molecules; 2024 Mar; 29(6):. PubMed ID: 38542895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
